Holen Sie sich die Stockscreener-App
1.18
11.32%
0.12
Schlusskurs vom Vortag:
$1.06
Offen:
$1.06
24-Stunden-Volumen:
2.62M
Relative Volume:
1.59
Marktkapitalisierung:
$217.75M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-179.82M
KGV:
-0.8872
EPS:
-1.33
Netto-Cashflow:
$-159.16M
1W Leistung:
+23.13%
1M Leistung:
+20.59%
6M Leistung:
+35.06%
1J Leistung:
+52.99%
1-Tages-Spanne:
$1.0401
$1.23
1-Wochen-Bereich:
$0.8451
$1.23
52-Wochen-Spanne:
$0.4993
$1.55
Gossamer Bio Inc Stock (GOSS) Company Profile
Firmenname
Gossamer Bio Inc
Sektor
Branche
Telefon
(858) 684-1300
Adresse
3115 MERRYFIELD ROW, SAN DIEGO, CA
Vergleichen Sie GOSS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GOSS
Gossamer Bio Inc
|
1.18 | 217.75M | 0 | -179.82M | -159.16M | -1.33 |
|
VRTX
Vertex Pharmaceuticals Inc
|
501.15 | 126.96B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
605.61 | 65.06B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
649.67 | 37.54B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
259.39 | 32.56B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
255.77 | 26.40B | 3.81B | -644.79M | -669.77M | -6.24 |
Gossamer Bio Inc Stock (GOSS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-06-25 | Eingeleitet | Oppenheimer | Outperform |
| 2024-04-05 | Fortgesetzt | Wedbush | Outperform |
| 2023-07-27 | Herabstufung | UBS | Buy → Neutral |
| 2023-03-07 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2023-03-01 | Eingeleitet | Guggenheim | Neutral |
| 2022-12-07 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2022-12-07 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2022-12-07 | Herabstufung | SMBC Nikko | Outperform → Neutral |
| 2022-10-20 | Eingeleitet | Goldman | Buy |
| 2022-09-21 | Eingeleitet | JP Morgan | Neutral |
| 2022-09-19 | Eingeleitet | Wedbush | Outperform |
| 2022-04-18 | Eingeleitet | Raymond James | Outperform |
| 2022-04-06 | Eingeleitet | UBS | Buy |
| 2022-01-10 | Hochstufung | SMBC Nikko | Neutral → Outperform |
| 2021-11-09 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2021-09-21 | Fortgesetzt | Piper Sandler | Overweight |
| 2020-06-29 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-04-22 | Eingeleitet | Piper Sandler | Overweight |
| 2020-02-27 | Eingeleitet | Barclays | Overweight |
| 2019-12-03 | Fortgesetzt | BofA/Merrill | Buy |
| 2019-10-30 | Eingeleitet | Berenberg | Buy |
| 2019-03-05 | Eingeleitet | Barclays | Overweight |
| 2019-03-05 | Eingeleitet | BofA/Merrill | Buy |
| 2019-03-05 | Eingeleitet | Evercore ISI | Outperform |
| 2019-03-05 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
Gossamer Bio Inc Aktie (GOSS) Neueste Nachrichten
Gossamer Bio: Initiating Hold As Late‐Stage Data Nears Inflection (GOSS) - Seeking Alpha
Selling Buzz: Gossamer Bio Inc [GOSS] Chief Medical Officer Aranda Richard sells 1,908 shares of the company - knoxdaily.com
Check out these key findings about Gossamer Bio Inc (GOSS) - Sete News
Geode Capital Management LLC Has $2.04 Million Stock Holdings in Gossamer Bio, Inc. (NASDAQ:GOSS) - Defense World
Was Gossamer Bio Inc (GOSS)’s session last reading good? - uspostnews.com
Gossamer Bio Inc (GOSS) Stock: A Year of Declines and Increases - investchronicle.com
Closing Strong: Gossamer Bio Inc (GOSS) Ends at 1.17, Up 0.86 from Last Close - DWinneX
Monitoring Gossamer Bio Inc (GOSS) after recent insider movements - knoxdaily.com
Gossamer Bio Inc (GOSS Stock: A Sea of Opportunity - investchronicle.com
Gossamer Bio Insider Confidence Rewarded, Stock Hits US$203m Market Cap - simplywall.st
Taking the lead: Gossamer Bio Inc (GOSS) - Sete News
Oppenheimer initates Gossamer Bio Inc (GOSS) rating to an Outperform - knoxdaily.com
GOSS’s price-to-cash ratio: Is it a good investment at the moment? - uspostnews.com
Stock Performance Spotlight: Gossamer Bio Inc (GOSS) Ends the Day at 0.83, Up by 1.77 - DWinneX
Pleasing Signs As A Number Of Insiders Buy Gossamer Bio Stock - Yahoo Finance
The Goldman Sachs Group Has Lowered Expectations for Gossamer Bio (NASDAQ:GOSS) Stock Price - Defense World
Is Gossamer Bio Inc. (NASDAQ:GOSS) the Best Penny Stock to Invest in Under $1? - Insider Monkey
11 Best Penny Stocks to Invest in Under $1 - Insider Monkey
Gossamer Bio, Inc. (GOSS): Among Stocks Under $10 that Will Triple - Insider Monkey
Nuvation Bio Inc. (NUVB): Among Stocks Under $10 that Will Triple - Yahoo Finance
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)April 8, 2025 - BioSpace
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rul - GuruFocus
Gossamer Bio Announces Inducement Grant Under - MarketScreener
10 Stocks Under $10 that Will Triple - Insider Monkey
Hypertension Clinical Trials and Studies 2025: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies - The Globe and Mail
Charles Schwab Investment Management Inc. Raises Stock Position in Gossamer Bio, Inc. (NASDAQ:GOSS) - Defense World
Is Gossamer Bio Inc. (GOSS) the Popular Penny Stock on Robinhood to Watch? - MSN
Cantor Fitzgerald Comments on Gossamer Bio FY2025 Earnings - Defense World
Is Gossamer Bio, Inc. (GOSS) The Hot Biotech Stock Under $5? - Insider Monkey
Gossamer Bio Inc (NASDAQ: GOSS) Analysts Think Could Fell -290.62% From Current Levels - Stocks Register
Gossamer Bio (GOSS): Among the Penny Stocks With Huge Upside Potential According to Analysts - Yahoo Finance
Gossamer Bio, Inc. (NASDAQ:GOSS) Position Decreased by Victory Capital Management Inc. - Defense World
10 Penny Stocks With Huge Upside Potential According To Analysts - Insider Monkey
10 Hot Biotech Stocks Under $5 - Insider Monkey
Q1 EPS Estimates for Gossamer Bio Reduced by HC Wainwright - Defense World
FY2028 EPS Forecast for Gossamer Bio Decreased by Analyst - Defense World
GOSSAMER BIO Earnings Preview: Recent $GOSS Insider Trading, Hedge Fund Activity, and More - Nasdaq
H.C. Wainwright maintains Buy on Gossamer Bio, $10 target By Investing.com - Investing.com South Africa
H.C. Wainwright maintains Buy on Gossamer Bio, $10 target - Investing.com
Wedbush Reiterates Outperform Rating for Gossamer Bio (NASDAQ:GOSS) - Defense World
Gossamer Bio Reports 2024 Financial Results and Progress - TipRanks
Gossamer Bio Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Gossamer Bio shares rise on Q4 earnings beat By Investing.com - Investing.com South Africa
Gossamer Bio shares rise on Q4 earnings beat - Investing.com India
Gossamer Bio Inc (GOSS) Q4 Earnings: EPS Loss of $0.15 Beats Est - GuruFocus.com
Gossamer Bio: Q4 Earnings Snapshot - mySA
Finanzdaten der Gossamer Bio Inc-Aktie (GOSS)
Umsatz
Nettogewinn
Free Cashflow
ENV
Gossamer Bio Inc-Aktie (GOSS) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Hasnain Faheem | President & CEO |
Jun 21 '24 |
Buy |
0.67 |
372,000 |
250,282 |
5,408,073 |
| Giraudo Bryan | COO/CFO |
Jun 18 '24 |
Buy |
0.59 |
100,000 |
59,110 |
480,010 |
| Smith Robert Paul JR | Chief Commercial Officer |
Jun 17 '24 |
Buy |
0.60 |
25,000 |
15,050 |
25,000 |
0.47%
2.63%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):